Literature DB >> 21716309

Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection.

Susse Kirkelund Hansen1, Martin Holm Rau, Helle Krogh Johansen, Oana Ciofu, Lars Jelsbak, Lei Yang, Anders Folkesson, Hanne Østergaard Jarmer, Kasper Aanæs, Christian von Buchwald, Niels Høiby, Søren Molin.   

Abstract

The opportunistic pathogen Pseudomonas aeruginosa is a frequent colonizer of the airways of patients suffering from cystic fibrosis (CF). Depending on early treatment regimens, the colonization will, with high probability, develop into chronic infections sooner or later, and it is important to establish under which conditions the switch to chronic infection takes place. In association with a recently established sinus surgery treatment program for CF patients at the Copenhagen CF Center, colonization of the paranasal sinuses with P. aeruginosa has been investigated, paralleled by sampling of sputum from the same patients. On the basis of genotyping and phenotypic characterization including transcription profiling, the diversity of the P. aeruginosa populations in the sinuses and the lower airways was investigated and compared. The observations made from several children show that the paranasal sinuses constitute an important niche for the colonizing bacteria in many patients. The paranasal sinuses often harbor distinct bacterial subpopulations, and in the early colonization phases there seems to be a migration from the sinuses to the lower airways, suggesting that independent adaptation and evolution take place in the sinuses. Importantly, before the onset of chronic lung infection, lineages with mutations conferring a large fitness benefit in CF airways such as mucA and lasR as well as small colony variants and antibiotic-resistant clones are part of the sinus populations. Thus, the paranasal sinuses potentially constitute a protected niche of adapted clones of P. aeruginosa, which can intermittently seed the lungs and pave the way for subsequent chronic lung infections.

Entities:  

Mesh:

Year:  2011        PMID: 21716309      PMCID: PMC3246239          DOI: 10.1038/ismej.2011.83

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  59 in total

1.  A comparison of microbiologic flora of the sinuses and airway among cystic fibrosis patients with maxillary antrostomies.

Authors:  A Dosanjh; S Lakhani; D Elashoff; C Chin; V Hsu; B Hilman
Journal:  Pediatr Transplant       Date:  2000-08

2.  Adaptive radiation in a heterogeneous environment.

Authors:  P B Rainey; M Travisano
Journal:  Nature       Date:  1998-07-02       Impact factor: 49.962

3.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

Review 4.  Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management.

Authors:  C Gysin; G A Alothman; B C Papsin
Journal:  Pediatr Pulmonol       Date:  2000-12

5.  Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  G Taccetti; S Campana; F Festini; M Mascherini; G Döring
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

6.  Protected environments allow parallel evolution of a bacterial pathogen in a patient subjected to long-term antibiotic therapy.

Authors:  A S Low; F M MacKenzie; I M Gould; I R Booth
Journal:  Mol Microbiol       Date:  2001-11       Impact factor: 3.501

7.  Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation.

Authors:  C A DeVries; D E Ohman
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

8.  Early infection and progression of cystic fibrosis lung disease.

Authors:  Christian Koch
Journal:  Pediatr Pulmonol       Date:  2002-09

9.  Population structure of Pseudomonas aeruginosa.

Authors:  Lutz Wiehlmann; Gerd Wagner; Nina Cramer; Benny Siebert; Peter Gudowius; Gracia Morales; Thilo Köhler; Christian van Delden; Christian Weinel; Peter Slickers; Burkhard Tümmler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-27       Impact factor: 11.205

10.  Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung.

Authors:  Melissa Starkey; Jason H Hickman; Luyan Ma; Niu Zhang; Susan De Long; Aaron Hinz; Sergio Palacios; Colin Manoil; Mary Jo Kirisits; Timothy D Starner; Daniel J Wozniak; Caroline S Harwood; Matthew R Parsek
Journal:  J Bacteriol       Date:  2009-03-27       Impact factor: 3.490

View more
  66 in total

1.  Long-term social dynamics drive loss of function in pathogenic bacteria.

Authors:  Sandra Breum Andersen; Rasmus Lykke Marvig; Søren Molin; Helle Krogh Johansen; Ashleigh S Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

Review 2.  Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.

Authors:  Mauricio López-Chacón; Joaquim Mullol; Laura Pujols
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 3.  Bacterial Pathogens and the Microbiome.

Authors:  Thad W Vickery; Vijay R Ramakrishnan
Journal:  Otolaryngol Clin North Am       Date:  2017-02       Impact factor: 3.346

4.  Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.

Authors:  Nicole Mayer-Hamblett; Margaret Kloster; Margaret Rosenfeld; Ronald L Gibson; George Z Retsch-Bogart; Julia Emerson; Valeria Thompson; Bonnie W Ramsey
Journal:  Clin Infect Dis       Date:  2015-05-13       Impact factor: 9.079

5.  Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.

Authors:  Nicole Mayer-Hamblett; Bonnie W Ramsey; Hemantha D Kulasekara; Daniel J Wolter; Laura S Houston; Christopher E Pope; Bridget R Kulasekara; Catherine R Armbruster; Jane L Burns; George Retsch-Bogart; Margaret Rosenfeld; Ronald L Gibson; Samuel I Miller; Umer Khan; Lucas R Hoffman
Journal:  Clin Infect Dis       Date:  2014-05-26       Impact factor: 9.079

6.  16S rRNA gene sequencing reveals site-specific signatures of the upper and lower airways of cystic fibrosis patients.

Authors:  Sarah K Lucas; Robert Yang; Jordan M Dunitz; Holly C Boyer; Ryan C Hunter
Journal:  J Cyst Fibros       Date:  2017-08-18       Impact factor: 5.482

7.  Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.

Authors:  Nicole Mayer-Hamblett; Margaret Rosenfeld; Ronald L Gibson; Bonnie W Ramsey; Hemantha D Kulasekara; George Z Retsch-Bogart; Wayne Morgan; Daniel J Wolter; Christopher E Pope; Laura S Houston; Bridget R Kulasekara; Umer Khan; Jane L Burns; Samuel I Miller; Lucas R Hoffman
Journal:  Am J Respir Crit Care Med       Date:  2014-08-01       Impact factor: 21.405

8.  Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection.

Authors:  Benjamin J Staudinger; Jocelyn Fraga Muller; Skarphéðinn Halldórsson; Blaise Boles; Angus Angermeyer; Dao Nguyen; Henry Rosen; Olafur Baldursson; Magnús Gottfreðsson; Guðmundur Hrafn Guðmundsson; Pradeep K Singh
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

9.  Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts.

Authors:  Søren Damkiær; Lei Yang; Søren Molin; Lars Jelsbak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

Review 10.  Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review.

Authors:  Maria E Møller; Mikkel C Alanin; Christian Grønhøj; Kasper Aanæs; Niels Høiby; Christian von Buchwald
Journal:  Am J Rhinol Allergy       Date:  2017-09-01       Impact factor: 2.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.